Page 94 - MemoriaOBN-Eng

RESEARCH GROUPS

á

ó
ó
ñ
íí

íá
óí

éí

í
í

ó
íè

PRPORGORGARMAMAE:
Grupo 3
ó
P6.PhysiopatholoDgeyporefsbiodny, Regulación del Metabolismo en la Obesidad
wTreaignhstohronmoeboisptoalsaisr

Group Members
Lead Researcher
í
Remesar Betlloch, Xavier
STAFF MEMBERS
Caldern Domnguez, Mara
í
Romero Romero, Mara Mar
Contact:
ASSOCIATED MEMBERS
Nutricin y Bromatologa
Facultad de Biologa. Universidad de Barcelona Alemany Lamana, Mariano
Ariza Piquer, Javier
C/. Diagonal, 643. 08028 Barcelona
Phone: (+34) 93 402 15 18
Asins Muoz, Guillermnina
Barbany Cahiz, Monserrat

Cabot Majem, Cristina
Calvo Mrquez, Merc
Main lines of research
Carrillo Blanchar, Manuel

Casals Farre, Nuria • Determine how the excess fat in the diet influences the catabolism of ami-
Esteve Rafols, Monserrat no acids and their role in inflammation. Analysis of urea cycle function i

Fernndez Lpez, Jos Antonio diferent tissues. Effects of high-energy diets.
Garca Gmez, Jorge
• Role of protein binding corticosterone (CBG) in the first stage of inflam-
Grasa Martnez, Mar
Herrero Rodrguez, Laura mation to evaluate the mechanism by which hormone fit into the tissue 13
and how can modulate the inflammatory response.
0
Malandrino, Mara Ida 2
• Role of CPT1 in the development of obesity-induced insulin resistance and RT
Marolowski, Kamil O
Ramrez Flores, Sara type 2 diabetes. In vitro and in vivo studies of fatty-acid oxidation and EP
R
Serra Cucurrull, Dolores
inflammation in liver and adipose tissue.
AL
U
• Appetite regulation. Role of fatty acids and CPT1A in the control of food NN
intake. Role of CPT1C in the brain.
A
/
• Bioinformatic modeling of CPT1 and its relationship with obesity and type N
OB
2 diabetes: in silico design of anti-obesity drugs. Study of derivates from R
BE
the potential anti-obesity drug C75 and their interaction with CPT1 in vitro, CI
and in vivo in the hypothalamus.
94